AU2001261628A1 - Cd28 synthebody for the modulation of immune responses - Google Patents
Cd28 synthebody for the modulation of immune responsesInfo
- Publication number
- AU2001261628A1 AU2001261628A1 AU2001261628A AU6162801A AU2001261628A1 AU 2001261628 A1 AU2001261628 A1 AU 2001261628A1 AU 2001261628 A AU2001261628 A AU 2001261628A AU 6162801 A AU6162801 A AU 6162801A AU 2001261628 A1 AU2001261628 A1 AU 2001261628A1
- Authority
- AU
- Australia
- Prior art keywords
- synthebody
- modulation
- immune responses
- immune
- responses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20448300P | 2000-05-16 | 2000-05-16 | |
US60204483 | 2000-05-16 | ||
PCT/US2001/015707 WO2001088159A2 (fr) | 2000-05-16 | 2001-05-16 | Anticorps synthetique cd28 servant a la modulation de responses immunitaires |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001261628A1 true AU2001261628A1 (en) | 2001-11-26 |
Family
ID=22758081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001261628A Abandoned AU2001261628A1 (en) | 2000-05-16 | 2001-05-16 | Cd28 synthebody for the modulation of immune responses |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001261628A1 (fr) |
WO (1) | WO2001088159A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050084967A1 (en) | 2002-06-28 | 2005-04-21 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
DE10240418A1 (de) * | 2002-09-02 | 2004-03-11 | Avontec Gmbh | Formulierung zur Einschleusung von Nukleinsäuren in eukaryotische Zellen |
WO2005021595A1 (fr) * | 2003-08-28 | 2005-03-10 | Euro-Celtique S.A. | Procedes utilisant les regles des regions de presentation des anticorps pour intervenir sur des anticorps |
SI1772465T1 (sl) | 2005-01-05 | 2009-06-30 | F Star Biotech Forsch & Entw | Sintetične imunoglobulinske domene z modificiranimi vezavnimi lastnostmi v regijah molekule, ki se razlikujejo od komplementarnost dolučujočih regij |
AT503902B1 (de) | 2006-07-05 | 2008-06-15 | F Star Biotech Forsch & Entw | Verfahren zur manipulation von immunglobulinen |
AT503889B1 (de) | 2006-07-05 | 2011-12-15 | Star Biotechnologische Forschungs Und Entwicklungsges M B H F | Multivalente immunglobuline |
PL3241842T3 (pl) | 2007-06-26 | 2024-06-10 | F-Star Therapeutics Limited | Prezentacja środków wiążących |
EP2113255A1 (fr) | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Immunoglobuline cytotoxique |
PL2344540T3 (pl) | 2008-10-02 | 2018-05-30 | Aptevo Research And Development Llc | Białka wiążące wiele celów antagonistyczne względem cd86 |
PE20121584A1 (es) | 2009-11-30 | 2012-11-29 | Genentech Inc | Composiciones y metodos para el diagnostico y el tratamiento de tumores |
EP2794878B1 (fr) | 2011-12-22 | 2020-03-18 | F.Hoffmann-La Roche Ag | Organisation d'un vecteur d'expression, nouveaux procédés de génération d'une cellule productrice et leur utilisation pour la production recombinante de polypeptides |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698679A (en) * | 1994-09-19 | 1997-12-16 | National Jewish Center For Immunology And Respiratory Medicine | Product and process for targeting an immune response |
GB9501079D0 (en) * | 1995-01-19 | 1995-03-08 | Bioinvent Int Ab | Activation of T-cells |
BR9815289A (pt) * | 1997-11-14 | 2001-12-26 | Euro Celtique Sa | Imunoglobulina modificada, molécula, ácidonucleico isolado, célula contendo o mesmo, animalnão-humano recombinante, composiçãofarmacêutica, composição de vacina, processospara identificar ou medir ou detectar um antìgenode câncer, um antìgeno de um agente de doençainfecciosa, um ligante, e um receptor em umaamostra a ser testada, kits para detecção de umantìgeno de câncer, de um antìgeno de um agentede doença infecciosa, de um receptor celular paraum agente de doença infecciosa, de um ligante, e deum antìgeno de câncer, processos de diagnósticoou de exame para a presença de ou umapredisposição para desenvolvimento de um câncertipificado pela presença aumentada de umantìgeno de câncer, e para a presença de umagente de doença infecciosa, processos detratamento ou de prevenção de um câncertipificado pela presença de um antìgeno de câncer,de uma doença infecciosa tipificada pela presençade um antìgeno de agente de doença infecciosa, ede uma doença causada por um agente de doençainfecciosa que se liga em um receptor celular,processos para modulação de atividade de umprimeiro membro de um par de ligação, processo deprodução de uma imunoglobulina modificada,processo de produção de um ácido nucleicocodificador de imunoglobulina modificada, e, ácidonucleico isolado |
-
2001
- 2001-05-16 AU AU2001261628A patent/AU2001261628A1/en not_active Abandoned
- 2001-05-16 WO PCT/US2001/015707 patent/WO2001088159A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001088159A2 (fr) | 2001-11-22 |
WO2001088159A3 (fr) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1290001A (en) | Antibodies | |
AU2002228890A1 (en) | Use of zwitterionic polysaccharides for the specific modulation of immune processes | |
AU4935000A (en) | Antibodies | |
AU1914501A (en) | Split repeater | |
AU2002317388A1 (en) | Conjugates for the modulation of immune responses | |
AU2001272815A1 (en) | Baby carrier | |
AU2002351634A1 (en) | One way clutch | |
AU2001261628A1 (en) | Cd28 synthebody for the modulation of immune responses | |
AU2003255787A1 (en) | Modulation of immune function | |
AU2003234443A1 (en) | Use of anti-cd1 antibodies for the modulation of immune responses | |
AU1555700A (en) | Clutch | |
AU2343901A (en) | Baby carrier | |
AU2541400A (en) | Controllable clutch | |
AU4155599A (en) | Clutches | |
AU2003269268A1 (en) | Modulation of immune function | |
AU7671700A (en) | Induction-heated disc tribometer | |
AU4682200A (en) | Flavor enhancing oils | |
AU2698300A (en) | Cooker | |
AU2002248646A1 (en) | Compositions and methods for modulating an immune response | |
AU2001262014A1 (en) | Baby carrier | |
AU2001256507A1 (en) | Modulation | |
AU7788600A (en) | Colon-tumour-associated antigens | |
AU2001291934A1 (en) | Means for regulating immune defences | |
AU2002324386A1 (en) | Compounds and methods for the modulation of immune responses | |
AU2002352392A1 (en) | Methods and means for modulating the immune response |